[go: up one dir, main page]

JPH0128005B2 - - Google Patents

Info

Publication number
JPH0128005B2
JPH0128005B2 JP55166478A JP16647880A JPH0128005B2 JP H0128005 B2 JPH0128005 B2 JP H0128005B2 JP 55166478 A JP55166478 A JP 55166478A JP 16647880 A JP16647880 A JP 16647880A JP H0128005 B2 JPH0128005 B2 JP H0128005B2
Authority
JP
Japan
Prior art keywords
parts
weight
volume
oleic acid
ethyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55166478A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5687517A (en
Inventor
Bakusufuei Nandooru
Harumoshi Ne Fugii Magudoruna
Suzentookirarui Zusuzusanna
Tosu Zorutan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of JPS5687517A publication Critical patent/JPS5687517A/ja
Publication of JPH0128005B2 publication Critical patent/JPH0128005B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP16647880A 1979-11-27 1980-11-26 Medicinal composition for durable effect type injection Granted JPS5687517A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2710A HU180740B (en) 1979-11-27 1979-11-27 Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity

Publications (2)

Publication Number Publication Date
JPS5687517A JPS5687517A (en) 1981-07-16
JPH0128005B2 true JPH0128005B2 (pl) 1989-05-31

Family

ID=10995877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16647880A Granted JPS5687517A (en) 1979-11-27 1980-11-26 Medicinal composition for durable effect type injection

Country Status (9)

Country Link
JP (1) JPS5687517A (pl)
AT (1) AT371339B (pl)
BE (1) BE886310A (pl)
DD (1) DD154802A5 (pl)
DE (1) DE3044753A1 (pl)
FR (1) FR2469924A1 (pl)
GB (1) GB2066068B (pl)
HU (1) HU180740B (pl)
IT (1) IT1149268B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210693B (en) * 1991-10-11 1995-06-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions for injections without tissue damages, containing sulfamethoxazol and trimetoprime
CN100376893C (zh) * 2006-08-18 2008-03-26 中国水产科学研究院黄海水产研究所 同时测定鱼肉中磺胺甲唑、乙酰化磺胺甲唑及甲氧苄啶的液相色谱法
CN113952296B (zh) * 2021-11-15 2023-10-13 山东新华制药股份有限公司 一种复方磺胺甲噁唑注射液的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631779A1 (de) * 1976-07-15 1978-01-19 Basf Ag Sulfonamid-trimethoprim-loesungen

Also Published As

Publication number Publication date
FR2469924A1 (fr) 1981-05-29
IT1149268B (it) 1986-12-03
IT8026227A0 (it) 1980-11-26
HU180740B (en) 1983-04-29
DE3044753A1 (de) 1981-06-19
DD154802A5 (de) 1982-04-21
BE886310A (fr) 1981-05-25
GB2066068B (en) 1983-08-24
ATA577380A (de) 1982-11-15
FR2469924B1 (pl) 1984-06-29
AT371339B (de) 1983-06-27
JPS5687517A (en) 1981-07-16
GB2066068A (en) 1981-07-08
DE3044753C2 (pl) 1990-05-10

Similar Documents

Publication Publication Date Title
EP0546018B1 (en) Pharmaceutical composition of florfenicol
ES2241198T3 (es) Preparacion aplicable percutaneamente que contiene hidrocloruro de donepezil.
ES2326426T3 (es) Formulaciones pastosas que comprenden silice.
RU2694368C2 (ru) Твердые фармацевтические композиции, содержащие производные биоптерина, и способы применения таких композиций
BRPI0613731A2 (pt) composição farmacêutica, recipiente enchido previamente, bem como uso de um açúcar para aprimorar a recuperação e/ou aumentar a atividade biológica de um membro da superfamìlia tgf-beta
JPS60105617A (ja) 骨炎及び骨髄炎予防治療組成物
JPH08501317A (ja) 抗菌性インターフェロン誘発性医薬品
JPH03169812A (ja) トリアセチンを含む活性持続性注射用処方剤
JPS647046B2 (pl)
EA013616B1 (ru) Инъекционные препараты диклофенака и его фармацевтически приемлемых солей
JPH02207018A (ja) 皮膚外用剤
JPH10502628A (ja) 長時間作用オキシテトラサイクリン組成物
JPS605567B2 (ja) オキシテトラサイクリンの調合液
CN112823787B (zh) 一种含有美洛昔康的注射液及其制备方法
JPH0128005B2 (pl)
WO2021033145A1 (en) Novel injectable formulations of artesunate
EP0238207B1 (en) Bactericidal mixtures
CN106924174A (zh) 一种关节腔注射用阿普斯特凝胶剂及其制备方法
RU2103997C1 (ru) Лекарственное средство для лечения заболеваний животных микробной этиологии, способ лечения желудочно-кишечных заболеваний животных микробной этиологии и способы лечения гинекологических заболеваний коров микробной этиологии
RU2182830C1 (ru) Таблетированная форма рекомбинантного человеческого эритропоэтина
SK74699A3 (en) An oil composition of dihydropolyprenols
JP2007045788A (ja) グリチルリチン酸高濃度水溶液の調製法
RU2007152C1 (ru) Офтальмологическое средство и способ его получения
CA1142434A (en) Pharmaceutical composition
RU2273480C2 (ru) Фармацевтическая композиция для лечения заболеваний микробной и паразитарной этиологии